CPI-169 is a potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2). CPI-169 was shown to inhibit tumor growth in a NHL xenograft model, reducing global H3K27me3.1 It has also been shown to synergize with the B-cell lymphoma inhibitor, ABT-199, to suppress the growth of NHL cell lines. Note: CPI-169 is a racemic mixture.
MedKoo Cat#: 407247
Name: CPI-169
CAS#: 1450655-76-1 (racemic mixture)
Chemical Formula: C27H36N4O5S
Exact Mass: 528.2406
Molecular Weight: 528.67
Elemental Analysis: C, 61.34; H, 6.86; N, 10.60; O, 15.13; S, 6.06
The following data is based on the product molecular weight 528.67 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |